节点文献

药品技术转让中“控股转让”规定的研究

Study on the regulation of "holding transfer" in technology transfer of drugs

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张迪宋民宪

【Author】 ZHANG Di;SONG Min-xian;Pharmacy College,Chengdu University of Traditional Chinese Medicine; The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicine; State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources Co-founded by Sichuan Province and MOST;

【机构】 成都中医药大学药学院中药材标准化教育部重点实验室中药资源系统研究与开发利用省部共建国家重点实验室培育基地

【摘要】 目的:对《药品技术转让注册管理规定》中"控股转让"相关条款进行分析,期望为政策制定者修订药品技术转让方面规定提供理论依据,以增加其适用性。方法:通过对药品技术转让中"控股转让"规定的合法性、合理性、必要性进行细致探讨,对该规定法理缺陷进行深入分析。结果与结论:"控股转让"规定合法性、合理性、必要性有待完善,因此建议有关部门予以调整。

【Abstract】 Objective: This paper mainly analyzes the regulation of holding transfer in "Administrative regulations for technology transfer registration of drugs", expecting to provide the theoretical basis for the policymakers to revise drug technology transfer regulations, which could increase its applicability. Method: The legal defects of the provision were analyzed by discussing its legitimacy, rationality, necessity. Result & Conclusion: The legitimacy, rationality, necessity of regulation of "Holding transfer" need to be perfect. It is proposed that the relevant departments can revise the regulation.

【关键词】 药品技术转让控股
【Key words】 Drugtechnology transferholding transfer
  • 【文献出处】 中药与临床 ,Pharmacy and Clinics of Chinese Materia Medica , 编辑部邮箱 ,2014年06期
  • 【分类号】R95
  • 【被引频次】2
  • 【下载频次】99
节点文献中: 

本文链接的文献网络图示:

本文的引文网络